You are here

Novartis mulls options including spinoff, IPO for Alcon unit


NOVARTIS AG proposed buying back US$5 billion of shares and said it's considering separating its embattled eye-care division after projecting that sales this year at Europe's second-biggest drugmaker will likely be largely unchanged from 2016.

Earnings, excluding some...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to